State of Wyoming’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,655
Closed -$133K 2011
2026
Q1
$133K Sell
1,655
-3,287
-67% -$271K 0.02% 1173
2025
Q4
$421K Sell
4,942
-291
-6% -$23.9K 0.05% 476
2025
Q3
$407K Sell
5,233
-1,691
-24% -$132K 0.05% 463
2025
Q2
$542K Buy
6,924
+4,248
+159% +$317K 0.07% 255
2025
Q1
$194K Buy
2,676
+741
+38% +$53K 0.03% 824
2024
Q4
$143K Buy
1,935
+1,087
+128% +$76.1K 0.02% 1024
2024
Q3
$56K Buy
848
+798
+1,596% +$58K 0.01% 1385
2024
Q2
$4.62K Buy
50
+14
+39% +$1.24K ﹤0.01% 1599
2024
Q1
$3.44K Sell
36
-1,270
-97% -$107K ﹤0.01% 1571
2023
Q4
$99.6K Buy
1,306
+1,274
+3,981% +$88.6K 0.02% 974
2023
Q3
$2.22K Sell
32
-1,631
-98% -$131K ﹤0.01% 1564
2023
Q2
$157K Sell
1,663
-173
-9% -$15K 0.05% 528
2023
Q1
$152K Sell
1,836
-827
-31% -$65K 0.05% 518
2022
Q4
$199K Buy
2,663
+684
+35% +$52.7K 0.07% 347
2022
Q3
$163K Buy
1,979
+1,692
+590% +$163K 0.08% 304
2022
Q2
$27K Sell
287
-1,088
-79% -$113K 0.02% 1314
2022
Q1
$162K Buy
1,375
+40
+3% +$4.49K 0.08% 298
2021
Q4
$173K Sell
1,335
-13
-1% -$1.52K 0.08% 289
2021
Q3
$153K Sell
1,348
-192
-12% -$21.9K 0.1% 255
2021
Q2
$159K Buy
1,540
+92
+6% +$8.67K 0.1% 263
2021
Q1
$121K Buy
+1,448
New +$122K 0.2% 94

Other funds holding EW

State of Wyoming's EW Position: Q2 2026 in Review

State of Wyoming sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 1,655 shares — an estimated $133K sold.

State of Wyoming first reported a position in EW in Q1 2021 and held it in 21 quarters. The position peaked at $542K in Q2 2025. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • State of Wyoming reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • State of Wyoming sold 1,655 Edwards Lifesciences shares in Q2 2026, an estimated $133K.
  • State of Wyoming first reported a position in Edwards Lifesciences in Q1 2021 and held it in 21 quarters.
  • State of Wyoming's Edwards Lifesciences position peaked at $542K in Q2 2025.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.